During the past decade, Women's Cancer Center of Nevada conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 53 clinical trials were completed, i.e. on average, 160.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 31 clinical trials were completed. i.e. 281.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Cancer Center of Nevada" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "Gynecologic Oncology Group" with 33 trials sponsored, "GOG Foundation" with 9 trials sponsored, "NRG Oncology" with 5 trials sponsored and "ASTORA Women's Health" with 5 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Cancer Center of Nevada" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 34 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 5 trials as a collaborator, "GOG Foundation" with 4 trials as a collaborator and "Gynecologic Oncology Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Women's Cancer Center of Nevada" are "Recurrent Ovarian Carcinoma" (19 trials), "Recurrent Fallopian Tube Carcinoma" (17 trials), "Recurrent Primary Peritoneal Carcinoma" (16 trials), "Cervical Adenocarcinoma" (11 trials) and "Cervical Adenosquamous Carcinoma" (11 trials). Many other conditions were trialed in "Women's Cancer Center of Nevada" in a lesser frequency.

Most popular intervention types in "Women's Cancer Center of Nevada" are "Drug" (72 trials), "Other" (64 trials), "Procedure" (28 trials), "Biological" (24 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Paclitaxel" (30 trials), "Quality-of-Life Assessment" (26 trials), "Carboplatin" (20 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "Women's Cancer Center of Nevada" are 93 trials for "Female" genders, 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Women's Cancer Center of Nevada". undefined are not yet recruiting, 8 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Women's Cancer Center of Nevada, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Cancer Center of Nevada, 3 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".